IGC Pharma, Inc. - COM NEW (IGC)

CUSIP: 45408X308

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM NEW
Total 13F shares
1,538,933
Share change
+1,119,736
Total reported value
$2,522,000
Price per share
$1.64
Number of holders
23
Value change
+$1,830,939
Number of buys
13
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 45408X308?
CUSIP 45408X308 identifies IGC - IGC Pharma, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2019

As of 30 Jun 2019, IGC Pharma, Inc. - COM NEW (IGC) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,538,933 shares. The largest 10 holders included VANGUARD GROUP INC, Carroll Financial Associates, Inc., GEODE CAPITAL MANAGEMENT, LLC, DEARBORN PARTNERS LLC, Anson Funds Management LP, Creative Planning, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, BANK OF MONTREAL /CAN/, and JANE STREET GROUP, LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.